At a glance
- Originator Chugai Pharmaceutical
- Class Antihypertensives; Benzopyrans; Bronchodilators; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Hypertension
Most Recent Events
- 10 Jul 1998 Discontinued-Preclinical for Asthma in Japan (Unknown route)
- 10 Jul 1998 Discontinued-Preclinical for Hypertension in Japan (Unknown route)